This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33375600
rdf:type
wikibase:Item
schema:description
บทความทางวิทยาศาสตร์ 2007年论文 wissenschaftlicher Artikel 2007年論文 article scientific 2007年論文 bilimsel makale mokslinis straipsnis bài báo khoa học scientific article vitskapeleg artikkel مقالة علمية article scientifique (publié 2007) naučni članak 2007년 논문 artikull shkencor article científic 2007年论文 научна статия 2007年論文 teaduslik artikkel tudományos cikk 2007 թուականի Յունիսին հրատարակուած գիտական յօդուած videnskabelig artikel (udgivet 2007) artículo científico publicado en 2007 2007 թվականի հունիսին հրատարակված գիտական հոդված artigo científico artykuł naukowy articol științific 2007年论文 наукова стаття, опублікована в червні 2007 2007年论文 artículu científicu espublizáu en 2007 научни чланак 2007年の論文 מאמר מדעי мақолаи илмӣ vědecký článek vitenskapelig artikkel scienca artikolo 2007年论文 vetenskaplig artikel სამეცნიერო სტატია 2007 nî lūn-bûn επιστημονικό άρθρο мақолаи илмӣ مقالهٔ علمی научни чланак artigo científico (publicado na 2007) 2007年論文 wetenschappelijk artikel 2007年论文 tieteellinen artikkeli سائنسی مضمون artigo científico (publicado na 2007) vedecký článok artikulong pang-agham научная статья 2007年論文 articolo scientifico ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ
p:P577
wds:Q33375600-15000B84-7F02-413B-A631-E5019135D42E
wdt:P577
2007-06-18T00:00:00Z
p:P407
wds:Q33375600-3B716311-78C2-45FC-90D6-799CF1489FEC
wdt:P407
wd:Q1860
p:P2093
wds:Q33375600-C31DA7D2-0F08-4DA4-BA38-BE61AB12308D wds:Q33375600-B0DF3E7D-4F7E-4D50-A498-44FDB67ED1F2 wds:Q33375600-AFD9CE4D-661B-4CE9-95F8-99C83055FDE7 wds:Q33375600-6BDEFA7B-C8D2-4AF5-84E6-2990EA782E7C wds:Q33375600-6C3ED8CE-098C-406F-9252-9E3CCE9F1550 wds:Q33375600-5EBC5A41-FB9C-4870-A769-97693172221B wds:Q33375600-3BED8EA6-E34D-4142-9D07-C501D97173A9 wds:Q33375600-3D3789C7-E400-4802-B8CE-5CF314F04C41 wds:Q33375600-36E55B19-7831-4247-A136-0D4D5BE3B7F5 wds:Q33375600-105B1054-CCE5-4AD6-AB5D-40A81F737290 wds:Q33375600-09E20025-CEF9-47B7-95E5-62F58F3A5D36
wdt:P2093
Cong Chen Elise A Olsen Stanley R Frankel Timothy M Kuzel Justin L Ricker Madeleine Duvic Jean Marie Arduino Youn H Kim Francine M Foss Theresa R Pacheco Sareeta Parker
rdfs:label
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
skos:prefLabel
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
schema:name
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
p:P1476
wds:Q33375600-0358163D-2A4F-499F-99BD-F98F437068DE
wdt:P1476
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
p:P304
wds:Q33375600-BD2871E3-1F02-46BD-80F1-E986CECB05A5
wdt:P304
3109-3115
p:P31
wds:Q33375600-7A652752-A90F-470D-B31A-0E5D188DF0BD
wdt:P31
wd:Q13442814
p:P921
wds:Q33375600-1DC3A189-75A5-4A21-BA19-28EA1B8114D5
wdt:P921
wd:Q6934595
p:P698
wds:Q33375600-61C3DBAF-AE02-410C-8CE9-43D3CC0B39DC
wdtn:P698
n7:17577020
wdt:P698
17577020
p:P1433
wds:Q33375600-53245664-3222-4BDC-8368-C51247D6F12A
wdt:P1433
wd:Q400292
p:P433
wds:Q33375600-DE29EFC6-2D92-48DB-97A1-EA40956B1338
p:P478
wds:Q33375600-3655B52D-3707-4B78-A269-894D52F036E3
wdt:P433
21
wdt:P478
25
p:P356
wds:Q33375600-0C4F2ADE-0EA5-4D2F-8057-D823FADCD8E8
wdtn:P356
n12:JCO.2006.10.2434
wdt:P356
10.1200/JCO.2006.10.2434
p:P5875
wds:Q33375600-672E7D44-2635-45B8-917E-5A0A5E5793F5
wdt:P5875
6260184